These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 17418148)

  • 1. Age-related structural and functional changes in the breast: multimodality correlation with digital mammography, computed tomography, magnetic resonance imaging, and positron emission tomography.
    Abramson RG; Mavi A; Cermik T; Basu S; Wehrli NE; Houseni M; Mishra S; Udupa J; Lakhani P; Maidment AD; Torigian DA; Alavi A
    Semin Nucl Med; 2007 May; 37(3):146-53. PubMed ID: 17418148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography.
    Wehrli NE; Bural G; Houseni M; Alkhawaldeh K; Alavi A; Torigian DA
    Semin Nucl Med; 2007 May; 37(3):195-205. PubMed ID: 17418152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of age-related morphological and functional changes of selected structures of the head and neck by computed tomography, magnetic resonance imaging, and positron emission tomography.
    Mahne A; El-Haddad G; Alavi A; Houseni M; Moonis G; Mong A; Hernandez-Pampaloni M; Torigian DA
    Semin Nucl Med; 2007 Mar; 37(2):88-102. PubMed ID: 17289457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of age-related changes in abdominal organ structure and function with computed tomography and positron emission tomography.
    Meier JM; Alavi A; Iruvuri S; Alzeair S; Parker R; Houseni M; Hernandez-Pampaloni M; Mong A; Torigian DA
    Semin Nucl Med; 2007 May; 37(3):154-72. PubMed ID: 17418149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in breast imaging. Although mammography remains standard for breast cancer screening, several newer technologies are helping to fine-tune diagnosis.
    Harv Womens Health Watch; 2010 May; 17(9):1-3. PubMed ID: 20593556
    [No Abstract]   [Full Text] [Related]  

  • 6. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving role of imaging modalities in inflammatory breast cancer.
    Le-Petross CH; Bidaut L; Yang WT
    Semin Oncol; 2008 Feb; 35(1):51-63. PubMed ID: 18308146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in imaging of inflammatory breast cancer.
    Yang WT
    Cancer; 2010 Jun; 116(11 Suppl):2755-7. PubMed ID: 20503406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
    Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
    Du Y; Cullum I; Illidge TM; Ell PJ
    J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of age-related changes in thoracic structure and function by computed tomography, magnetic resonance imaging, and positron emission tomography.
    Well DS; Meier JM; Mahne A; Houseni M; Hernandez-Pampaloni M; Mong A; Mishra S; Zhuge Y; Souza A; Udupa JK; Alavi A; Torigian DA
    Semin Nucl Med; 2007 Mar; 37(2):103-19. PubMed ID: 17289458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of multidetector row computed tomography in patient with breast cancer.
    Kang DK; Kim MJ; Jung YS; Yim H
    J Comput Assist Tomogr; 2008; 32(4):583-98. PubMed ID: 18664847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aging of the heart and blood vessels: a consideration of anatomy and physiology in the era of computed tomography, magnetic resonance imaging, and positron emission tomographic imaging methods with special consideration of atherogenesis.
    Botvinick EH; Perini R; Bural G; Chen W; Chryssikos T; Houseni M; Hernandez-Pampaloni M; Torigian DA; Alavi A
    Semin Nucl Med; 2007 Mar; 37(2):120-43. PubMed ID: 17289459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG positron emission tomography/computed tomography and the "underground map" appearance in imaging Horton's arteritis.
    Abdul Jalil N; Abdul Rahim N; Md Shalleh N; Rossetti C
    Singapore Med J; 2008 Jul; 49(7):e178-82. PubMed ID: 18695852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
    Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
    Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of gastrointestinal stromal tumors and assessment of benefit from systemic therapy.
    Boonsirikamchai P; Podoloff DA; Choi H
    Hematol Oncol Clin North Am; 2009 Feb; 23(1):35-48, vii. PubMed ID: 19248969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging features of primary extranodal lymphomas.
    Chua SC; Rozalli FI; O'Connor SR
    Clin Radiol; 2009 Jun; 64(6):574-88. PubMed ID: 19414080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
    Hennings J; Hellman P; Ahlström H; Sundin A
    Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone imaging in metastatic breast cancer.
    Hamaoka T; Madewell JE; Podoloff DA; Hortobagyi GN; Ueno NT
    J Clin Oncol; 2004 Jul; 22(14):2942-53. PubMed ID: 15254062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.